Page last updated: 2024-10-24

carisoprodol and Parathyroid Diseases

carisoprodol has been researched along with Parathyroid Diseases in 1 studies

Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.

Parathyroid Diseases: Pathological processes of the PARATHYROID GLANDS. They usually manifest as hypersecretion or hyposecretion of PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FUJITA, T1
MORII, H1
ORIMO, H1

Other Studies

1 other study available for carisoprodol and Parathyroid Diseases

ArticleYear
[Therapy of parathyroid gland diseases].
    Naika. Internal medicine, 1962, Volume: 10

    Topics: Carisoprodol; Dihydrotachysterol; Humans; Hyperparathyroidism; Hypoparathyroidism; Meprobamate; Para

1962